Toxoplasmosis and secondary Guillain‐Barré associated with ruxolitinib as graft‐versus‐host disease treatment

Gonzalez Vicent Marta; Molina Blanca; Fabregat María; Segura María; Diaz Miguel A.

首页> 外文期刊>Pediatric blood & cancer >Toxoplasmosis and secondary Guillain‐Barré associated with ruxolitinib as graft‐versus‐host disease treatment

【24h】

Toxoplasmosis and secondary Guillain‐Barré associated with ruxolitinib as graft‐versus‐host disease treatment

机译：弓形虫病和仲乳房与Ruxolitinib相关，作为移植物与宿主疾病治疗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric blood & cancer》 |2019年第1期|共2页
作者
Gonzalez Vicent Marta; Molina Blanca; Fabregat María; Segura María; Diaz Miguel A.;
展开▼
作者单位

Stem Cell Transplant UnitHospital Ni?o JesúsMadrid Spain;

Stem Cell Transplant UnitHospital Ni?o JesúsMadrid Spain;

Stem Cell Transplant UnitHospital Ni?o JesúsMadrid Spain;

Stem Cell Transplant UnitHospital Ni?o JesúsMadrid Spain;

Stem Cell Transplant UnitHospital Ni?o JesúsMadrid Spain;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. Toxoplasmosis and secondary Guillain‐Barré associated with ruxolitinib as graft‐versus‐host disease treatment [J] . Gonzalez Vicent Marta, Molina Blanca, Fabregat María, Pediatric blood & cancer . 2019,第1期

机译：弓形虫病和仲乳房与Ruxolitinib相关，作为移植物与宿主疾病治疗
2. Ruxolitinib as a promising treatment for corticosteroid‐refractory graft‐ versus versus ‐host disease [J] . Assouan Deborah, Lebon Delphine, Charbonnier Amandine, British Journal of Haematology . 2018,第5期

机译：Ruxolitinib作为皮质类固醇难治嫁接移植术与verse-host疾病的有前途的治疗方法
3. Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host disease. [J] . Kristina Maas-Bauer, Chrissoula Kiote-Schmidt, Hartmut Bertz, Bone marrow transplantation . 2021,第4期

机译：Ruxolitinib-ECP组合治疗难治性严重慢性接枝 - 宿主病。
4. Platelet-rich plasma autologous eyedrops and punctal plug occlusion for dry eye secondary to graft versus host disease [C] . Sanz-Marco E, Udaondo P, Garcia-Delpech S, International Symposium on Ocular Pharmacology and Therapeutics . 2011

机译：富含血小板的等离子体自体眼镜和泪塞闭塞，用于移植物与宿主病
5. The MAGIC Algorithm Probability (MAP) Is a Validated Response Biomarker of Treatment for Acute Graft-Versus-Host Disease [D] . Srinagesh, Hrishikesh Krishna. 2020

机译：魔术算法概率（地图）是急性接枝腹膜疾病治疗的验证响应生物标志物
6. Ruxolitinib in GvHD (RIG) study: a multicenter randomized phase 2 trial to determine the response rate of Ruxolitinib and best available treatment (BAT) versus BAT in steroid-refractory acute graft-versus-host disease (aGvHD) (NCT02396628) [O] . Nikolas von Bubnoff, Gabriele Ihorst, Olga Grishina, 2018

机译：鲁索替尼在GvHD（RIG）研究中：一项多中心随机2期试验用于测定鲁索替尼和类固醇难治性急性移植物抗宿主病（aGvHD）的最佳可用治疗（BAT）与BAT的反应率（NCT02396628）
7. Ruxolitinib in GvHD (RIG) study: a multicenter, randomized phase 2 trial to determine the response rate of Ruxolitinib and best available treatment (BAT) versus BAT in steroid-refractory acute graft-versus-host disease (aGvHD) (NCT02396628) [O] . Nikolas von Bubnoff, Gabriele Ihorst, Olga Grishina, 2018

机译：ruxolitinib在GVHD（钻机）研究：多中心，随机阶段2试验，以确定罗尾蛋白和最佳可用治疗（BAT）与蝙蝠在类固醇耐火急性移植物 - 宿主病（AGVHD）中的响应率（NCT02396628）

Toxoplasmosis and secondary Guillain‐Barré associated with ruxolitinib as graft‐versus‐host disease treatment

著录项

相似文献

相关主题

期刊订阅